Gsk (GSK) Free Cash Flow (2009 - 2026)
Gsk (GSK) recorded Free Cash Flow of $6.45 billion in the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) Free Cash Flow (2009 - 2026) Analysis & Trends
On a TTM basis, Gsk's Free Cash Flow came in at $6.7 billion as of Sep 8, 2026; for the year ended Dec 31, 2025, it came in at $13.57 billion, up 14.6% from the prior year.
- Annual Free Cash Flow has increased for three straight years, with a five-year compound annual growth rate of 6.9% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Free Cash Flow came in at $11.84 billion in the year ended Dec 31, 2024 (+1.1%), $11.7 billion in the year ended Dec 31, 2023 (+4.1%), $11.25 billion in the year ended Dec 31, 2022 (-19.8%) and $14.02 billion in the year ended Dec 31, 2021 (+44.1%).
- The figure for the quarter ended Sep 8, 2026 is the highest quarterly Free Cash Flow since the quarter ended Dec 31, 2023.
- Peak year-over-year performance for Free Cash Flow in the last five years was growth of 781.8% in the quarter ended Dec 31, 2021, against a decline of 82.8% in the quarter ended Mar 31, 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 7.76 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 7.30 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.11 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 4.48 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 6.20 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 3.63 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 3.49 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 3.43 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 302.00 Mn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.12 Bn |
| Dec 31, 2025 | -3.77 Bn |
| Mar 31, 2025 | 1.90 Bn |
| Dec 31, 2024 | 4.02 Bn |
| Mar 31, 2024 | 1.74 Bn |
| Dec 31, 2023 | 10.65 Bn |
| Mar 31, 2023 | 632.06 Mn |
| Dec 31, 2022 | 9.83 Bn |
| Mar 31, 2022 | 3.22 Bn |
| Dec 31, 2021 | 10.28 Bn |
| Mar 31, 2021 | 733.59 Mn |
| Dec 31, 2020 | 4.44 Bn |
| Mar 31, 2020 | 1.49 Bn |
| Dec 31, 2019 | 5.06 Bn |
| Sep 30, 2019 | 3.45 Bn |
| Mar 31, 2019 | 1.15 Bn |
| Dec 31, 2018 | 5.95 Bn |
| Mar 31, 2018 | 1.56 Bn |
| Dec 31, 2017 | 11.67 Bn |
| Sep 30, 2017 | 2.97 Bn |
API Access
Gsk Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();